Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats

Drug and Alcohol Dependence

Volumn 70, Issue 1, 2003, Pages 105-108

  Colombo, Giancarlo ^a   Serra, Salvatore ^a,b   Brunetti, Giuliana ^a,b   Vacca, Giovanni ^a,b   Carai, Mauro A M ^b   Gessa, Gian Luigi ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Neuroscienze PharmaNess Scarl   (Italy)

Author keywords

Alcohol deprivation effect (ADE); Baclofen; GABAB receptor; Relapse like drinking; Sardinian alcohol preferring (sP) rats

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALCOHOL; BACLOFEN;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

ALCOHOLISM; ANIMALS; BACLOFEN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE MODELS, ANIMAL; ETHANOL; GABA AGONISTS; MALE; RATS; SUBSTANCE WITHDRAWAL SYNDROME; TEMPERANCE;

ANIMALIA;

EID: 0037401523     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00333-2     Document Type: Article

References (21)

1. Addolorato G., Caputo F., Capristo E., Domenicali M., Bernardi M., Janiri L., Agabio R., Colombo G., Gessa G.L., Gasbarrini G. Baclofen efficacy in reducing alcohol craving and intake-a preliminary double blind randomised controlled study. Alcohol. 37:2002;504-508.
2. Agabio R., Carai M.A.M., Lobina C., Pani M., Reali R., Vacca G., Gessa G.L., Colombo G. Development of short-lasting alcohol deprivation effect (ADE) in Sardinian alcohol-preferring rats. Alcohol. 21:2000;59-62.
3. Boening J.A.L., Lesch O.M., Spanagel R., Wolffgramm J., Narita M., Sinclair D., Mason B.J., Wiesbeck G.A. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Alcohol Clin. Exp. Res. 25:2001;127S-131S.
4. Campbell U.C., Lac S.T., Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology. 143:1999;209-214.
5. Colombo G., Agabio R., Carai M.A.M., Lobina C., Pani M., Reali R., Addolorato G., Gessa G.L. Ability of baclofen in reducing alcohol intake and withdrawal severity: I-Preclinical evidence. Alcohol Clin. Exp. Res. 24:2000;58-66.
6. Colombo G., Serra S., Brunetti G., Atzori G., Pani M., Vacca G., Addolorato G., Froestl W., Carai M.A.M., Gessa G.L. The GABAB receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol. 37:2002;499-503.
7. Cowen M.S., Rezvani A.H., Jarrott B., Lawrence A.J. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in μ-opioid receptor density. Alcohol Clin. Exp. Res. 23:1999;1008-1014.
8. Garbutt J.C., West S.L., Carey T.S., Lohr K.N., Crews F.T. Pharmacological treatment of alcohol dependence. A review of the evidence. J. Am. Med. Assoc. 281:1999;1318-1325.
9. Heyser C.J., Schulteis G., Durbin P., Koob G.F. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology. 18:1998;125-133.
10. Hölter S.M., Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology. 145:1999;360-369.
11. Hölter S.M., Danysz W., Spanagel R. Evidence for alcohol anti-craving properties of memantine. Eur. J. Pharmacol. 314:1996;R1-R2.
12. Hölter S.M., Landgraf R., Zieglgänsberger W., Spanagel R. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin. Exp. Res. 21:1997;862-868.
13. Hölter S.M., Danysz W., Spanagel R. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J. Pharmacol. Exp. Ther. 292:2000;545-552.
14. Hölter S.M., Henniger M.S.H., Lipkowski A.W., Spanagel R. Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology. 153:2000;93-102.
15. Kranzler H.R. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol. 35:2000;537-547.
16. McBride W.J., Le A.-D., Noronha A. Central nervous system mechanisms in alcohol relapse. Alcohol Clin. Exp. Res. 26:2002;280-286.
17. Morse R.M., Flavin D.K. The definition of alcoholism. J. Am. Med. Assoc. 268:1992;1012-1014.
18. Salimov R.M., Salimova N.B. L-Glutamate abolishes differential responses to alcohol deprivation in mice. Alcohol. 10:1993;251-257.
19. Serra S., Brunetti G., Pani M., Vacca G., Carai M.A.M., Gessa G.L., Colombo G. Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur. J. Pharmacol. 443:2002;95-97.
20. Schuckit M.A. Drug and Alcohol Abuse: a Clinical Guide to Diagnosis and Treatment. Fourth Ed. 1995;Plenum Publishing Corporation, New York.
21. Spanagel R., Hölter S.M., Allingham K., Landgraf R., Zieglgänsberger W. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur. J. Pharmacol. 305:1996;39-44.